Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 -
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pre treatment Recurrence Score:18-25 Letrozole + Palbociclib|DRUG: Pre treatment Recurrence Score:26-100 Letrozole + Palbociclib
Sponsor: MedSIR
Collaborators: Pfizer